Contrast CT, PET/CT assess cancer therapy for melanoma

March 8, 2012

Dynamic contrast-enhanced CT and FDG-PET/CT can provide additional information to evaluate and confirm how well melanoma patients respond to immune-modulated and antiangiogenic cancer therapy, according to researchers from Dana-Farber Cancer Institute.